Proto Script Pharmaceutical Corp.
PSCR · OTC
9/30/2017 | 6/30/2017 | 3/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Revenue | $252 | $114 | $138 | $100 |
| % Growth | 120.3% | -17.3% | 37.8% | – |
| Cost of Goods Sold | $38 | $84 | $31 | $100 |
| Gross Profit | $214 | $30 | $107 | $1 |
| % Margin | 84.8% | 26.3% | 77.6% | 0.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $299 | $274 | $369 | $380 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $299 | $274 | $369 | $380 |
| Operating Income | -$85 | -$244 | -$262 | -$380 |
| % Margin | -33.9% | -213.5% | -189.3% | -378.2% |
| Other Income/Exp. Net | -$198 | -$88 | -$244 | -$6,885 |
| Pre-Tax Income | -$284 | -$333 | -$506 | -$7,264 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$284 | -$333 | -$506 | -$7,264 |
| % Margin | -112.6% | -290.8% | -365.8% | -7,238.9% |
| EPS | -0.006 | -0.007 | -0.003 | -0.077 |
| % Growth | 14.7% | -100% | 95.6% | – |
| EPS Diluted | -0.006 | -0.007 | -0.003 | -0.077 |
| Weighted Avg Shares Out | 49,140 | 49,140 | 150,751 | 93,912 |
| Weighted Avg Shares Out Dil | 49,140 | 49,140 | 150,751 | 93,912 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $118 | $119 | $412 | $0 |
| Depreciation & Amortization | $3 | $2 | $2 | $2 |
| EBITDA | -$164 | -$211 | -$92 | -$378 |
| % Margin | -64.9% | -184.8% | -66.7% | -376.7% |